Consider OPT and the jump it had post successful phase 2 trial...there is no reason that bot couldn't do the same. Similar MC.
One could certainly argue that bot has a much superior market opportunity in acne should the drug btx1503 be shown to be effective...nevermind the other drugs in the pipeline.
Consider OPT and the jump it had post successful phase 2...
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
39.0¢ |
Change
0.010(2.63%) |
Mkt cap ! $678.7M | |||
| Open | High | Low | Value | Volume |
| 38.0¢ | 39.0¢ | 37.5¢ | $1.052M | 2.748M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 303011 | 38.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.0¢ | 752826 | 12 |
View Market Depth
| Last trade - 12.03pm 01/08/2024 (20 minute delay) ? |
| BOT (ASX) Chart |